{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T23:51:12Z","timestamp":1778111472370,"version":"3.51.4"},"reference-count":35,"publisher":"SAGE Publications","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.3233\/jad-180365","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T15:22:24Z","timestamp":1530631344000},"page":"981-993","source":"Crossref","is-referenced-by-count":18,"title":["Do Cardiometabolic Risk Factors Influence Amyloid, Tau, and Neuronal Function in APOE4 Carriers and Non-Carriers in Alzheimer\u2019s Disease Trajectory?"],"prefix":"10.1177","volume":"64","author":[{"given":"Grazia Daniela","family":"Femminella","sequence":"first","affiliation":[{"name":"Department of Medicine, Imperial College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genevieve","family":"Taylor-Davies","sequence":"additional","affiliation":[{"name":"Department of Medicine, Imperial College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Scott","sequence":"additional","affiliation":[{"name":"Department of Medicine, Imperial College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Edison","sequence":"additional","affiliation":[{"name":"Department of Medicine, Imperial College London, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-180365_ref1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/B978-0-12-800149-3.00005-6","article-title":"Genetics of Alzheimer\u2019s disease","volume":"87","author":"Chouraki","year":"2014","journal-title":"Adv Genet"},{"key":"10.3233\/JAD-180365_ref2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S1474-4422(14)70136-X","article-title":"Potentialfor primary prevention of Alzheimer\u2019s disease: An analysis ofpopulation-based data","volume":"13","author":"Norton","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180365_ref3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/alzrt269","article-title":"Alzheimer\u2019s diseasedrug-development pipeline: Few candidates, frequent failures","volume":"6","author":"Cummings","year":"2014","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-180365_ref4","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1136\/bmj.39261.471806.55","article-title":"Derivation and validation of QRISK, a new cardiovasculardisease risk score for the United Kingdom: Prospective open cohortstudy","volume":"335","author":"Hippisley-Cox","year":"2007","journal-title":"BMJ"},{"key":"10.3233\/JAD-180365_ref5","doi-asserted-by":"crossref","first-page":"c2442","DOI":"10.1136\/bmj.c2442","article-title":"An independent and external validation of QRISK2 cardiovascular disease risk score: A prospective opencohort study","volume":"340","author":"Collins","year":"2010","journal-title":"BMJ"},{"key":"10.3233\/JAD-180365_ref6","doi-asserted-by":"crossref","first-page":"e4181","DOI":"10.1136\/bmj.e4181","article-title":"Predicting the 10 year risk of cardiovascular disease in the United Kingdom: Independent and external validation of an updated version of QRISK2","volume":"344","author":"Collins","year":"2012","journal-title":"BMJ"},{"key":"10.3233\/JAD-180365_ref7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3233\/JAD-2011-110086","article-title":"Interaction between vascularfactors and the APOE epsilon4 allele in predicting rate of progression in Alzheimer\u2019s disease","volume":"26","author":"Mielke","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180365_ref8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/WAD.0b013e3181d1b99b","article-title":"Nonstroke cardiovascular disease and risk of Alzheimer disease anddementia","volume":"24","author":"Eriksson","year":"2010","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-180365_ref9","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1111\/j.1582-4934.2008.00296.x","article-title":"Apolipoprotein E epsilon4 magnifies lifestyle risks fordementia: A population-based study","volume":"12","author":"Kivipelto","year":"2008","journal-title":"J Cell Mol Med"},{"key":"10.3233\/JAD-180365_ref10","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1212\/01.wnl.0000210447.19748.0b","article-title":"Coronary artery disease is associated withAlzheimer disease neuropathology in APOE4 carriers","volume":"66","author":"Beeri","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-180365_ref11","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000320484","article-title":"Midlife smoking, apolipoprotein E and risk of dementia and Alzheimer\u2019s disease: A population-based cardiovascularrisk factors, aging and dementia study","volume":"30","author":"Rusanen","year":"2010","journal-title":"Dement Geriatr CognDisord"},{"key":"10.3233\/JAD-180365_ref12","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3233\/JAD-132363","article-title":"Heart diseases and long-term risk of dementia and Alzheimer\u2019s disease: A population-based CAIDE study","volume":"42","author":"Rusanen","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180365_ref13","first-page":"108021","article-title":"Cardiovascular risk and hippocampal thickness in Alzheimer\u2019sdisease","volume":"2013","author":"Donix","year":"2013","journal-title":"Int J Alzheimers Dis"},{"key":"10.3233\/JAD-180365_ref14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jalz.2010.03.006","article-title":"Clinical core of the Alzheimer\u2019s Disease Neuroimaging Initiative: Progress and plans","volume":"6","author":"Aisen","year":"2010","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-180365_ref15","first-page":"e1","article-title":"2014 Update of the Alzheimer\u2019s Disease Neuroimaging Initiative: Areview of papers published since its inception","volume":"11","author":"Weiner","year":"2015","journal-title":"AlzheimersDement"},{"key":"10.3233\/JAD-180365_ref16","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1001\/archgenpsychiatry.2011.155","article-title":"Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10 years before the onset of Alzheimer dementia","volume":"69","author":"Buchhave","year":"2012","journal-title":"Arch Gen Psychiatry"},{"key":"10.3233\/JAD-180365_ref17","unstructured":"Landau SM , Jagust W (2015) Florbetapir processing methods. Alzheimer\u2019s Disease Neuroimaging Initiative. https:\/\/adni.bitbucket.io\/reference\/docs\/UCBERKELEYAV45\/ADNI_AV45_Methods_JagustLab_06.25.15.pdf"},{"key":"10.3233\/JAD-180365_ref18","doi-asserted-by":"crossref","first-page":"3334","DOI":"10.1073\/pnas.061509598","article-title":"Declining brain activity in cognitively normal apolipoprotein Eepsilon 4 heterozygotes: A foundation for using positron emissiontomography to efficiently test treatments to prevent Alzheimer\u2019sdisease","volume":"98","author":"Reiman","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3233\/JAD-180365_ref19","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/JAD-2012-112117","article-title":"Risk classification in mildcognitive impairment patients for developing Alzheimer\u2019s disease","volume":"30","author":"Zhou","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-180365_ref20","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/brain\/awp062","article-title":"Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer\u2019s disease:Implications for sequence of pathological events in Alzheimer\u2019s disease","volume":"132","author":"Jack","year":"2009","journal-title":"Brain"},{"key":"10.3233\/JAD-180365_ref21","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PET positivity in dementia syndromes: Ameta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/JAD-180365_ref22","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid beta deposition,neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019sdisease: A prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180365_ref23","doi-asserted-by":"crossref","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","article-title":"Human apoE isoformsdifferentially regulate brain amyloid-beta peptide clearance","volume":"3","author":"Castellano","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.3233\/JAD-180365_ref24","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","article-title":"A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoringversus control to prevent cognitive decline in at-risk elderlypeople (FINGER): A randomised controlled trial","volume":"385","author":"Ngandu","year":"2015","journal-title":"Lancet"},{"key":"10.3233\/JAD-180365_ref25","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1186\/s12916-015-0377-5","article-title":"The potential for prevention of dementia acrosstwo decades: The prospective, population-based Rotterdam Study","volume":"13","author":"de Bruijn","year":"2015","journal-title":"BMC Med"},{"key":"10.3233\/JAD-180365_ref26","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1016\/j.pnpbp.2008.05.015","article-title":"The effects of omega-3 fatty acids monotherapy inAlzheimer\u2019s disease and mild cognitive impairment: A preliminaryrandomized double-blind placebo-controlled study","volume":"32","author":"Chiu","year":"2008","journal-title":"ProgNeuropsychopharmacol Biol Psychiatry"},{"key":"10.3233\/JAD-180365_ref27","first-page":"205","article-title":"Insulin signaling inthe central nervous system: Learning to survive","volume":"79","author":"van der Heide","year":"2006","journal-title":"ProgNeurobiol"},{"key":"10.3233\/JAD-180365_ref28","first-page":"464","article-title":"Longitudinal inflammation, cognitivedecline, and Alzheimer\u2019s disease: A mini-review","volume":"96","author":"Bettcher","year":"2014","journal-title":"Clin PharmacolTher"},{"key":"10.3233\/JAD-180365_ref29","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","article-title":"The projected effect of risk factorreduction on Alzheimer\u2019s disease prevalence","volume":"10","author":"Barnes","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-180365_ref30","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1016\/j.neurobiolaging.2011.10.002","article-title":"Coronary risk correlates with cerebral amyloid deposition","volume":"33","author":"Reed","year":"2012","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-180365_ref31","first-page":"1","article-title":"Summary health statisticsfor US adults: National health interview survey, 2012","author":"Blackwell","year":"2014","journal-title":"Vitaland health statistics. Series 10, Data from the National HealthSurvey"},{"key":"10.3233\/JAD-180365_ref32","first-page":"1","article-title":"Prevalence of obesity among adults and youth: United States, 2011\u20132014","volume":"219","author":"Ogden","year":"2015","journal-title":"NCHS Data Brief"},{"key":"10.3233\/JAD-180365_ref33","unstructured":"Centers for Disease Control and Prevention (2013) The state of aging and health in America 2013. Centers for Disease Control and Prevention, US Department of Health and Human Services, Atlanta, GA."},{"key":"10.3233\/JAD-180365_ref34","doi-asserted-by":"crossref","first-page":"b2584","DOI":"10.1136\/bmj.b2584","article-title":"An independent external validation and evaluation of QRISK cardiovascular risk prediction: A prospectiveopen cohort study","volume":"339","author":"Collins","year":"2009","journal-title":"BMJ"},{"key":"10.3233\/JAD-180365_ref35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.jalz.2016.02.010","article-title":"Neuroinflammation in Alzheimer\u2019sdisease: Current evidence and future directions","volume":"12","author":"Calsolaro","year":"2016","journal-title":"Alzheimers Dement"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-180365","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:07:26Z","timestamp":1777370846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-180365"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":35,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.3233\/jad-180365","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]}}}